BioSpace News Archive

NASH is similar to cirrhosis of the liver but occurs in people that drink little or no alcohol. It is related to the obesity epidemic and affects at least three to five percent of the adult population worldwide. Many believe that combination therapies will be the best way to approach treating NASH, because it has several components.

To strengthen its competitiveness and increase its efficiency, Essity is today announcing the following changes to its organizational structure and Executive Management Team.

Voluntis and AstraZeneca announced that they have been awarded the 2018 Prix Galien – MedStartUp Award for Best Patient Engagement Technology for eCO.

Reviva Pharmaceuticals, Inc. announced today that it has been selected as a winner of the 2018 Red Herring Top 100 Global award, which recognizes the leading private companies from North America, Europe, and Asia, celebrating these companies’ innovations and technologies across their respective industries.

MYR Pharma today announced that the results of 48 weeks of administration of Myrcludex, MYR`s first-in-class entry inhibitor for treatment of hepatitis B and D infection, will be presented at the Presidential Plenary Session of the upcoming AASLD meeting in San Francisco

“REKOOP” is the first Bedding solution to use Applied DNA’s CertainT Platform and Reliance Industries’ Recron GreenGold fiber for source verification and traceability of recycled polyester across the supply chain; Arrives in US Q1 2019

NeoTract today announced the company received the Phoenix 2018 Emerging Growth Company Award at the 25th Annual Phoenix Medical Device and Diagnostic Conference.

REKOVELLE® helps women achieve a more predictable and targeted ovarian response

Anixa Biosciences today announced that it will present data from its ongoing studies utilizing Cchek™, Anixa’s artificial intelligence (AI) driven early cancer detection technology.

He will join the Board as of November 1, 2018, and will also become a member of the Board’s Audit Committee, Nomination Committee, and Compensation Committee.